Organization
Johnson & Johnson
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Johnson & Johnson
... continuous launch of new products by players namely Procter & Gamble, Johnson & Johnson, etc. has contributed significantly in the development of overall market. Moreover, ...
... benefit job creation in the U.S." -Dominic Caruso, chief financial officer, Johnson & Johnson Johnson & Johnson Chief Financial Officer Dominic Caruso said the new ...
... Johnson & Johnson (J&J) skincare brand Neutrogena has revealed details of its new dermatologist-grade ...
... Healthcare, Gilead Sciences, Inc., GlaxoSmithKline, IBM Corporation, Illumina, Inc., Intomics A/S, JOHNSON & JOHNSON, Laboratory Corporation of America, Merck KGaA, Novartis AG, Pfizer, Inc., QIAGEN, ...
... Johnson Consumer Inc. - a division of New Brunswick, N.J.-based Johnson & Johnson (NYSE: JNJ) - to create 25 positions by Dec. 31, 2020, five ...
... Johnson Consumer Inc. - a division of New Brunswick, N.J.-based Johnson & Johnson (NYSE: JNJ) - on Jan. 8 will seek the Orlando City Council's ...
... chief information officer with FDA, SVP of pharma R&D IT at Johnson & Johnson and executive director of Harvard Medical School’s Center for Biomedical Informatics. ...
... Johnson & Johnson Innovation LLCtoday announced more than a dozen new collaborations to drive ...
... Q Core Medical - Medtronic - MedSolve Technologies - Medline - Johnson & Johnson - Insulet Corporation - Hospira - Fresenius Kabi - Disetronic (Roche) ...
... Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a ...
... Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced that data from a Phase 2 clinical study of intranasal ...
... PA - Janssen Biotech, Inc. ('Janssen'), a Janssen Pharmaceutical Company of Johnson & Johnson, announced today that it has entered into a worldwide collaboration and ...
... Janssen Biotech, Inc. ("Janssen"), a Janssen Pharmaceutical Company of Johnson & Johnson, announced today that it has entered into a worldwide collaboration and ...
... New Brunswick - Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. ...
... New Brunswick - Johnson & Johnson (NYSE: JNJ) will participate in the 36th Annual JP Morgan Health Care ...
... New Brunswick - Johnson & Johnson (NYSE: JNJ) will participate in the 36th Annual JP Morgan Health Care ...
... New Brunswick, NJ - Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. ...
... New Brunswick, NJ - Johnson & Johnson (NYSE: JNJ) will participate in the 36th Annual JP Morgan Health Care ...
... Johnson & Johnson (NYSE: JNJ) will participate in the 36th Annual JP Morgan Health Care ...
... Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. ...
... Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Merck & Co., Inc., AstraZeneca, Johnson and Johnson, Bristol Myers Squibb Company, Novartis Ag, and Allergen Plc as some ...
... in October 2017 for approximately $1.045 billion. Mr. Laxminarain first joined Johnson & Johnson in 1986 where he held roles of increasing responsibility, including President ...
... recently served as Executive Vice President and Worldwide Chairman for the Johnson & Johnson ("J&J") (NYSE: JNJ) Medical Devices group. Over the course of his ...
... through his role as Vice President and Head of Transactions at Johnson & Johnson (J&J) Innovation in Boston. At J&J, he helped build the company's ...
... addition, Jennifer Turgiss, DrPH., Vice President, Behavior Science & Advanced Analytics, Johnson & Johnson Health and Wellness Solutions, will be giving Tuesday's Keynote presentation onThe ...
... Johnson & Johnson Innovation, today announced a collaboration with the Shanghai Municipal Government, Pudong ...
... infections. The new study is testing a two-vaccine combination developed by Johnson & Johnson (J&J) with the US National Institutes of Health (NIH) and the ...
Want to see the full history on Johnson & Johnson? Upgrade to RelSci Pro now!
Start My Free Trial